Discover how innovative lymphoma treatments are transforming patient outcomes, from targeted therapies to immunotherapy ...

The potential for cell and gene therapies is growing, offering groundbreaking treatments for rare genetic disorders and ...

Researchers with City of Hope and MSK have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...

"Full House" star Dave Coulier revealed this week that he is cancer-free after undergoing chemotherapy following a diagnosis ...

Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...

In an inspiring twist of fate, beloved actor Dave Coulier is sharing his triumphant health journey after battling stage 3 non ...

He originally got the diagnosis in October 2024. “(My doctors) said, ‘Hey, we wish we had better news, but you have ...

Dave Coulier and his “Full House” family are celebrating the announcement that he has beaten Non-Hodgkin Lymphoma. The actor ...

Dave Coulier says he is celebrating a significant victory in his health journey after being cancer-free post-diagnosis with ...

clonoSEQ testing for patients with MCL is currently available for clinical use as a laboratory-developed test performed at Adaptive's CLIA-certified lab in Seattle. clonoSEQ testing in MCL has also ...